[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f6cDirk23xPDZlIb37ZvY_yFeZXG-jwJIbAjtya1CydY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":31,"phaseBuckets":81,"rows":88},"Instituto Mexicano del Seguro Social",[4],119,false,18,24,48064,75,[13,16,18,20,23,25,27,29],{"name":14,"count":15},"Postoperative Pain",3,{"name":17,"count":15},"Covid19",{"name":19,"count":15},"Bariatric Surgery Candidate",{"name":21,"count":22},"Quality of Life",2,{"name":24,"count":22},"Renal Insufficiency",{"name":26,"count":22},"HIV",{"name":28,"count":22},"Weight Loss",{"name":30,"count":22},"Postoperative Pain Management",[32,37,42,47,52,57,62,67,71,76],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT06788158","Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis","2025-01-01","Incobotulinum Toxin A",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT06602622","Change in Body Weight and BMI in PWH with DOR\u002F3TC\u002FTDF Compared with INSTI","2025-11-14","Integrase inhibitor",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT06787976","Effect of Dolutegravir Compared With Darunavir\u002FCobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.","2025-12-21","Dolutegravir",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT06632184","Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy","2026-03-31","Ondansetron Intraperitoneal Lavage",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT07295223","Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)","2026-08","Dapagliflozin 10 MG Oral",{"nctId":58,"briefTitle":59,"date":60,"intervention":61},"NCT07406971","Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke","2026-09-30","Capsaicin Transmucosal Oral Film",{"nctId":63,"briefTitle":64,"date":65,"intervention":66},"NCT07031063","Safety, Tolerability and Effectiveness of DTG\u002F3TC vs BIC\u002FTAF\u002FFTC in PWH Without Antiretroviral Experience","2026-12-01","DTG\u002F3TC",{"nctId":68,"briefTitle":69,"date":70,"intervention":56},"NCT07297589","Epicardial Cardiac Fat-CT (EPIC-CT)","2027-01",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT06811142","Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence","2027-02-01","Botulinum Toxin Type A",{"nctId":77,"briefTitle":78,"date":79,"intervention":80},"NCT07073846","Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.","2027-05-01","Intravenous Lidocaine infusion + Standard Anesthesia",[82,83,84,85,86,87],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[89,117,135,164,182,200,218,243,261,286,311,329,359,390,412,434,458,476,500,526,551,578,603,637,678,703,721,747,765,783,810,828,854,881,899,917,942,973,991,1009,1038,1056,1080,1107,1125,1151,1177,1202,1227,1252,1277,1306,1332,1360,1385,1411,1429,1453,1478,1506],{"intervention":41,"totalTrials":90,"cells":91},1,{"EARLY_PHASE1":92,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":115},{"trials":93,"activeCount":94},[],0,{"trials":96,"activeCount":94},[],{"trials":98,"activeCount":94},[],{"trials":100,"activeCount":94},[],{"trials":102,"activeCount":90,"soonestReadout":40},[103],{"nctId":38,"briefTitle":39,"status":104,"phases":105,"primaryCompletion":40,"completion":40,"start":106,"enrollment":107,"conditions":108,"interventions":113},"RECRUITING",[86],"2024-08-14",108,[26,109,110,111,112,28],"HIV Associate Weight Loss","HIV-1 Infection","Integrase Inhibitors, HIV; HIV PROTEASE INHIB","Weight Change",[41,114],"Doravirine + tenofovir DF + lamivudine",{"trials":116,"activeCount":94},[],{"intervention":114,"totalTrials":90,"cells":118},{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":125,"PHASE4":127,"NA":133},{"trials":120,"activeCount":94},[],{"trials":122,"activeCount":94},[],{"trials":124,"activeCount":94},[],{"trials":126,"activeCount":94},[],{"trials":128,"activeCount":90,"soonestReadout":40},[129],{"nctId":38,"briefTitle":39,"status":104,"phases":130,"primaryCompletion":40,"completion":40,"start":106,"enrollment":107,"conditions":131,"interventions":132},[86],[26,109,110,111,112,28],[41,114],{"trials":134,"activeCount":94},[],{"intervention":80,"totalTrials":90,"cells":136},{"EARLY_PHASE1":137,"PHASE1":139,"PHASE2":141,"PHASE3":143,"PHASE4":145,"NA":162},{"trials":138,"activeCount":94},[],{"trials":140,"activeCount":94},[],{"trials":142,"activeCount":94},[],{"trials":144,"activeCount":94},[],{"trials":146,"activeCount":90,"soonestReadout":79},[147],{"nctId":77,"briefTitle":78,"status":104,"phases":148,"primaryCompletion":79,"completion":149,"start":150,"enrollment":151,"conditions":152,"interventions":158},[86],"2027-07-01","2025-10-06",104,[153,14,30,154,155,156,157],"Morbid Obesity Requiring Bariatric Surgery","Postoperative Analgesia","Postoperative Adjuvant Treatment","Postoperative Inflammatory Markers","Postoperative Inflammatory Response",[80,159,160,161],"Intravenous Dexmedetomidine infusion + Standard Anesthesia","Lidocaine + Dexmedetomidine Combination (LIDEX) + Standard Anesthesia","0.9 % Saline Placebo + Standard Anesthesia",{"trials":163,"activeCount":94},[],{"intervention":159,"totalTrials":90,"cells":165},{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":174,"NA":180},{"trials":167,"activeCount":94},[],{"trials":169,"activeCount":94},[],{"trials":171,"activeCount":94},[],{"trials":173,"activeCount":94},[],{"trials":175,"activeCount":90,"soonestReadout":79},[176],{"nctId":77,"briefTitle":78,"status":104,"phases":177,"primaryCompletion":79,"completion":149,"start":150,"enrollment":151,"conditions":178,"interventions":179},[86],[153,14,30,154,155,156,157],[80,159,160,161],{"trials":181,"activeCount":94},[],{"intervention":160,"totalTrials":90,"cells":183},{"EARLY_PHASE1":184,"PHASE1":186,"PHASE2":188,"PHASE3":190,"PHASE4":192,"NA":198},{"trials":185,"activeCount":94},[],{"trials":187,"activeCount":94},[],{"trials":189,"activeCount":94},[],{"trials":191,"activeCount":94},[],{"trials":193,"activeCount":90,"soonestReadout":79},[194],{"nctId":77,"briefTitle":78,"status":104,"phases":195,"primaryCompletion":79,"completion":149,"start":150,"enrollment":151,"conditions":196,"interventions":197},[86],[153,14,30,154,155,156,157],[80,159,160,161],{"trials":199,"activeCount":94},[],{"intervention":161,"totalTrials":90,"cells":201},{"EARLY_PHASE1":202,"PHASE1":204,"PHASE2":206,"PHASE3":208,"PHASE4":210,"NA":216},{"trials":203,"activeCount":94},[],{"trials":205,"activeCount":94},[],{"trials":207,"activeCount":94},[],{"trials":209,"activeCount":94},[],{"trials":211,"activeCount":90,"soonestReadout":79},[212],{"nctId":77,"briefTitle":78,"status":104,"phases":213,"primaryCompletion":79,"completion":149,"start":150,"enrollment":151,"conditions":214,"interventions":215},[86],[153,14,30,154,155,156,157],[80,159,160,161],{"trials":217,"activeCount":94},[],{"intervention":46,"totalTrials":90,"cells":219},{"EARLY_PHASE1":220,"PHASE1":222,"PHASE2":224,"PHASE3":226,"PHASE4":228,"NA":241},{"trials":221,"activeCount":94},[],{"trials":223,"activeCount":94},[],{"trials":225,"activeCount":94},[],{"trials":227,"activeCount":94},[],{"trials":229,"activeCount":90,"soonestReadout":45},[230],{"nctId":43,"briefTitle":44,"status":231,"phases":232,"primaryCompletion":45,"completion":233,"start":234,"enrollment":235,"conditions":236,"interventions":239},"NOT_YET_RECRUITING",[86],"2026-01-25","2025-06-19",140,[26,237,238],"Insomnia","Anxiety",[46,240],"Darunavir\u002FCobicistat",{"trials":242,"activeCount":94},[],{"intervention":240,"totalTrials":90,"cells":244},{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":251,"PHASE4":253,"NA":259},{"trials":246,"activeCount":94},[],{"trials":248,"activeCount":94},[],{"trials":250,"activeCount":94},[],{"trials":252,"activeCount":94},[],{"trials":254,"activeCount":90,"soonestReadout":45},[255],{"nctId":43,"briefTitle":44,"status":231,"phases":256,"primaryCompletion":45,"completion":233,"start":234,"enrollment":235,"conditions":257,"interventions":258},[86],[26,237,238],[46,240],{"trials":260,"activeCount":94},[],{"intervention":66,"totalTrials":90,"cells":262},{"EARLY_PHASE1":263,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":271,"NA":284},{"trials":264,"activeCount":94},[],{"trials":266,"activeCount":94},[],{"trials":268,"activeCount":94},[],{"trials":270,"activeCount":94},[],{"trials":272,"activeCount":90,"soonestReadout":65},[273],{"nctId":63,"briefTitle":64,"status":104,"phases":274,"primaryCompletion":65,"completion":275,"start":276,"enrollment":277,"conditions":278,"interventions":282},[86],"2028-12-01","2025-04-01",124,[279,280,281],"HIV Infection","Metabolic Syndrome","Antiretroviral Treatment",[66,283],"Bictegravir",{"trials":285,"activeCount":94},[],{"intervention":51,"totalTrials":90,"cells":287},{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":309},{"trials":289,"activeCount":94},[],{"trials":291,"activeCount":94},[],{"trials":293,"activeCount":94},[],{"trials":295,"activeCount":94},[],{"trials":297,"activeCount":90,"soonestReadout":50},[298],{"nctId":48,"briefTitle":49,"status":299,"phases":300,"primaryCompletion":50,"completion":50,"start":301,"enrollment":302,"conditions":303,"interventions":307},"ACTIVE_NOT_RECRUITING",[86],"2025-12-01",40,[30,304,305,306],"Laparoscopic Cholecystectomy","Ondansetron","Postoperative Nausea and Vomiting",[51,308],"Saline Intraperitoneal Lavage",{"trials":310,"activeCount":94},[],{"intervention":308,"totalTrials":90,"cells":312},{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":321,"NA":327},{"trials":314,"activeCount":94},[],{"trials":316,"activeCount":94},[],{"trials":318,"activeCount":94},[],{"trials":320,"activeCount":94},[],{"trials":322,"activeCount":90,"soonestReadout":50},[323],{"nctId":48,"briefTitle":49,"status":299,"phases":324,"primaryCompletion":50,"completion":50,"start":301,"enrollment":302,"conditions":325,"interventions":326},[86],[30,304,305,306],[51,308],{"trials":328,"activeCount":94},[],{"intervention":283,"totalTrials":22,"cells":330},{"EARLY_PHASE1":331,"PHASE1":333,"PHASE2":335,"PHASE3":337,"PHASE4":339,"NA":345},{"trials":332,"activeCount":94},[],{"trials":334,"activeCount":94},[],{"trials":336,"activeCount":94},[],{"trials":338,"activeCount":94},[],{"trials":340,"activeCount":90,"soonestReadout":65},[341],{"nctId":63,"briefTitle":64,"status":104,"phases":342,"primaryCompletion":65,"completion":275,"start":276,"enrollment":277,"conditions":343,"interventions":344},[86],[279,280,281],[66,283],{"trials":346,"activeCount":94},[347],{"nctId":348,"briefTitle":349,"status":350,"phases":351,"primaryCompletion":352,"completion":353,"start":354,"enrollment":355,"conditions":356,"interventions":358},"NCT06629480","Incidence of Metabolic Syndrome in People Living With HIV Without ExperienCe to ART Who Start DoLutegravir Based-Regimen Compared With BictegrAvir Based-RegimeN","COMPLETED",[87],"2024-02-24","2024-02-28","2021-06-25",378,[281,279,357],"Metabolic Cardiovascular Syndrome",[283],{"intervention":56,"totalTrials":22,"cells":360},{"EARLY_PHASE1":361,"PHASE1":363,"PHASE2":365,"PHASE3":367,"PHASE4":386,"NA":388},{"trials":362,"activeCount":94},[],{"trials":364,"activeCount":94},[],{"trials":366,"activeCount":94},[],{"trials":368,"activeCount":22,"soonestReadout":55},[369,378],{"nctId":53,"briefTitle":54,"status":104,"phases":370,"primaryCompletion":55,"completion":371,"start":372,"enrollment":373,"conditions":374,"interventions":376},[85],"2026-09","2025-12-30",44,[375],"Acute Myocardial Infarction With ST Elevation",[56,377],"Semaglutide",{"nctId":68,"briefTitle":69,"status":104,"phases":379,"primaryCompletion":70,"completion":380,"start":372,"enrollment":381,"conditions":382,"interventions":385},[85],"2027-03",136,[383,384],"STEMI - ST Elevation Myocardial Infarction","Epicardial Fat",[56,377],{"trials":387,"activeCount":94},[],{"trials":389,"activeCount":94},[],{"intervention":377,"totalTrials":22,"cells":391},{"EARLY_PHASE1":392,"PHASE1":394,"PHASE2":396,"PHASE3":398,"PHASE4":408,"NA":410},{"trials":393,"activeCount":94},[],{"trials":395,"activeCount":94},[],{"trials":397,"activeCount":94},[],{"trials":399,"activeCount":22,"soonestReadout":55},[400,404],{"nctId":53,"briefTitle":54,"status":104,"phases":401,"primaryCompletion":55,"completion":371,"start":372,"enrollment":373,"conditions":402,"interventions":403},[85],[375],[56,377],{"nctId":68,"briefTitle":69,"status":104,"phases":405,"primaryCompletion":70,"completion":380,"start":372,"enrollment":381,"conditions":406,"interventions":407},[85],[383,384],[56,377],{"trials":409,"activeCount":94},[],{"trials":411,"activeCount":94},[],{"intervention":61,"totalTrials":90,"cells":413},{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":428,"PHASE4":430,"NA":432},{"trials":415,"activeCount":94},[],{"trials":417,"activeCount":94},[],{"trials":419,"activeCount":90,"soonestReadout":60},[420],{"nctId":58,"briefTitle":59,"status":104,"phases":421,"primaryCompletion":60,"completion":422,"start":423,"enrollment":424,"conditions":425,"interventions":427},[84],"2026-10-31","2025-09-01",46,[426],"Ischemic Stroke",[61],{"trials":429,"activeCount":94},[],{"trials":431,"activeCount":94},[],{"trials":433,"activeCount":94},[],{"intervention":36,"totalTrials":90,"cells":435},{"EARLY_PHASE1":436,"PHASE1":438,"PHASE2":450,"PHASE3":452,"PHASE4":454,"NA":456},{"trials":437,"activeCount":94},[],{"trials":439,"activeCount":90,"soonestReadout":35},[440],{"nctId":33,"briefTitle":34,"status":299,"phases":441,"primaryCompletion":35,"completion":276,"start":442,"enrollment":443,"conditions":444,"interventions":448},[83],"2024-09-01",20,[445,446,447],"Plantar Fasciitis of Both Feet","Pain","Function",[36,449],"Glucocorticoid",{"trials":451,"activeCount":94},[],{"trials":453,"activeCount":94},[],{"trials":455,"activeCount":94},[],{"trials":457,"activeCount":94},[],{"intervention":449,"totalTrials":90,"cells":459},{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":468,"PHASE3":470,"PHASE4":472,"NA":474},{"trials":461,"activeCount":94},[],{"trials":463,"activeCount":90,"soonestReadout":35},[464],{"nctId":33,"briefTitle":34,"status":299,"phases":465,"primaryCompletion":35,"completion":276,"start":442,"enrollment":443,"conditions":466,"interventions":467},[83],[445,446,447],[36,449],{"trials":469,"activeCount":94},[],{"trials":471,"activeCount":94},[],{"trials":473,"activeCount":94},[],{"trials":475,"activeCount":94},[],{"intervention":75,"totalTrials":90,"cells":477},{"EARLY_PHASE1":478,"PHASE1":490,"PHASE2":492,"PHASE3":494,"PHASE4":496,"NA":498},{"trials":479,"activeCount":90,"soonestReadout":74},[480],{"nctId":72,"briefTitle":73,"status":299,"phases":481,"primaryCompletion":74,"completion":482,"start":483,"enrollment":484,"conditions":485,"interventions":489},[82],"2030-02-01","2025-01-28",200,[486,487,488],"Spasticity","Stroke","Neurological Rehabilitation",[75],{"trials":491,"activeCount":94},[],{"trials":493,"activeCount":94},[],{"trials":495,"activeCount":94},[],{"trials":497,"activeCount":94},[],{"trials":499,"activeCount":94},[],{"intervention":501,"totalTrials":90,"cells":502},"collagen-povidone solution",{"EARLY_PHASE1":503,"PHASE1":505,"PHASE2":507,"PHASE3":509,"PHASE4":511,"NA":524},{"trials":504,"activeCount":94},[],{"trials":506,"activeCount":94},[],{"trials":508,"activeCount":94},[],{"trials":510,"activeCount":94},[],{"trials":512,"activeCount":94},[513],{"nctId":514,"briefTitle":515,"status":350,"phases":516,"primaryCompletion":517,"completion":518,"start":519,"enrollment":520,"conditions":521,"interventions":523},"NCT06396819","Collagen-povidone for Diabetic Seniors' Tenosynovitis",[86],"2024-01-01","2024-04-01","2023-01-01",25,[522],"Diabetes Complications",[501],{"trials":525,"activeCount":94},[],{"intervention":527,"totalTrials":90,"cells":528},"Bezafibrate",{"EARLY_PHASE1":529,"PHASE1":531,"PHASE2":533,"PHASE3":535,"PHASE4":537,"NA":549},{"trials":530,"activeCount":94},[],{"trials":532,"activeCount":94},[],{"trials":534,"activeCount":94},[],{"trials":536,"activeCount":94},[],{"trials":538,"activeCount":94},[539],{"nctId":540,"briefTitle":541,"status":350,"phases":542,"primaryCompletion":543,"completion":543,"start":544,"enrollment":545,"conditions":546,"interventions":548},"NCT02291796","Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction",[86],"2013-12","2011-01",100,[547],"Acute Myocardial Infarction",[527],{"trials":550,"activeCount":94},[],{"intervention":552,"totalTrials":90,"cells":553},"Perioperative magnesium sulfate",{"EARLY_PHASE1":554,"PHASE1":556,"PHASE2":558,"PHASE3":560,"PHASE4":562,"NA":576},{"trials":555,"activeCount":94},[],{"trials":557,"activeCount":94},[],{"trials":559,"activeCount":94},[],{"trials":561,"activeCount":94},[],{"trials":563,"activeCount":94},[564],{"nctId":565,"briefTitle":566,"status":567,"phases":568,"primaryCompletion":569,"completion":570,"start":571,"enrollment":151,"conditions":572,"interventions":575},"NCT05227716","Clinical Response to Magnesium Sulfate as an Adjunct in the Anesthesia","UNKNOWN",[86],"2023-12-31","2024-07-31","2022-10-01",[573,574],"Anesthesia and Analgesia","Magnesium Sulfate",[552],{"trials":577,"activeCount":94},[],{"intervention":579,"totalTrials":90,"cells":580},"Dapagliflozin",{"EARLY_PHASE1":581,"PHASE1":583,"PHASE2":585,"PHASE3":587,"PHASE4":589,"NA":601},{"trials":582,"activeCount":94},[],{"trials":584,"activeCount":94},[],{"trials":586,"activeCount":94},[],{"trials":588,"activeCount":94},[],{"trials":590,"activeCount":94},[591],{"nctId":592,"briefTitle":593,"status":567,"phases":594,"primaryCompletion":569,"completion":595,"start":596,"enrollment":597,"conditions":598,"interventions":600},"NCT04783870","Effect of Dapagliflozin on LV Remodeling Post AMI",[86],"2024-12-31","2021-03-03",60,[599],"Myocardial Infarction",[579],{"trials":602,"activeCount":94},[],{"intervention":604,"totalTrials":22,"cells":605},"Atorvastatin",{"EARLY_PHASE1":606,"PHASE1":608,"PHASE2":610,"PHASE3":612,"PHASE4":633,"NA":635},{"trials":607,"activeCount":94},[],{"trials":609,"activeCount":94},[],{"trials":611,"activeCount":94},[],{"trials":613,"activeCount":94},[614,624],{"nctId":615,"briefTitle":616,"status":350,"phases":617,"primaryCompletion":618,"completion":619,"start":620,"enrollment":621,"conditions":622,"interventions":623},"NCT02522117","Atorvastatin in the Recipient's Kidney Graft From a Living Donor",[85],"2016-12","2018-01","2015-08",48,[24],[604],{"nctId":625,"briefTitle":626,"status":350,"phases":627,"primaryCompletion":628,"completion":629,"start":630,"enrollment":621,"conditions":631,"interventions":632},"NCT02355704","Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney",[85],"2014-04","2014-07","2012-01",[24],[604],{"trials":634,"activeCount":94},[],{"trials":636,"activeCount":94},[],{"intervention":638,"totalTrials":22,"cells":639},"Intravenous Dexamethasone",{"EARLY_PHASE1":640,"PHASE1":642,"PHASE2":644,"PHASE3":646,"PHASE4":674,"NA":676},{"trials":641,"activeCount":94},[],{"trials":643,"activeCount":94},[],{"trials":645,"activeCount":94},[],{"trials":647,"activeCount":94},[648,660],{"nctId":649,"briefTitle":650,"status":350,"phases":651,"primaryCompletion":652,"completion":653,"start":654,"enrollment":655,"conditions":656,"interventions":658},"NCT02305173","Dexamethasone and Respiratory Function After Mastectomy",[85],"2015-11","2016-11","2014-11",120,[657],"Respiratory; Disorder, Functional, Impaired",[638,659],"intravenous salin water",{"nctId":661,"briefTitle":662,"status":350,"phases":663,"primaryCompletion":664,"completion":665,"start":666,"enrollment":667,"conditions":668,"interventions":671},"NCT01116713","Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer",[85],"2010-03","2010-05","2009-06",70,[14,669,670],"Postoperative Nausea","Postoperative Vomiting",[672,673],"intravenous dexamethasone","Homologated placebo.",{"trials":675,"activeCount":94},[],{"trials":677,"activeCount":94},[],{"intervention":679,"totalTrials":90,"cells":680},"Metronidazole",{"EARLY_PHASE1":681,"PHASE1":683,"PHASE2":685,"PHASE3":687,"PHASE4":699,"NA":701},{"trials":682,"activeCount":94},[],{"trials":684,"activeCount":94},[],{"trials":686,"activeCount":94},[],{"trials":688,"activeCount":94},[689],{"nctId":690,"briefTitle":691,"status":350,"phases":692,"primaryCompletion":693,"completion":694,"start":695,"enrollment":373,"conditions":696,"interventions":698},"NCT02328144","Effectiveness of Metronidazole in Pain Control Posthemorrhoidectomy",[85],"2014-08","2014-10","2013-07",[697],"Hemorrhoids",[679],{"trials":700,"activeCount":94},[],{"trials":702,"activeCount":94},[],{"intervention":659,"totalTrials":90,"cells":704},{"EARLY_PHASE1":705,"PHASE1":707,"PHASE2":709,"PHASE3":711,"PHASE4":717,"NA":719},{"trials":706,"activeCount":94},[],{"trials":708,"activeCount":94},[],{"trials":710,"activeCount":94},[],{"trials":712,"activeCount":94},[713],{"nctId":649,"briefTitle":650,"status":350,"phases":714,"primaryCompletion":652,"completion":653,"start":654,"enrollment":655,"conditions":715,"interventions":716},[85],[657],[638,659],{"trials":718,"activeCount":94},[],{"trials":720,"activeCount":94},[],{"intervention":722,"totalTrials":90,"cells":723},"Methylprednisolone Acetate",{"EARLY_PHASE1":724,"PHASE1":726,"PHASE2":728,"PHASE3":730,"PHASE4":743,"NA":745},{"trials":725,"activeCount":94},[],{"trials":727,"activeCount":94},[],{"trials":729,"activeCount":94},[],{"trials":731,"activeCount":94},[732],{"nctId":733,"briefTitle":734,"status":350,"phases":735,"primaryCompletion":736,"completion":736,"start":737,"enrollment":302,"conditions":738,"interventions":740},"NCT03794505","Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis",[85],"2018-08-30","2018-04-01",[739],"Shoulder Arthritis",[722,741,742],"Lidocaine 2% Injectable Solution","Ropivacaine HCl Inj 7.5 MG\u002FML",{"trials":744,"activeCount":94},[],{"trials":746,"activeCount":94},[],{"intervention":741,"totalTrials":90,"cells":748},{"EARLY_PHASE1":749,"PHASE1":751,"PHASE2":753,"PHASE3":755,"PHASE4":761,"NA":763},{"trials":750,"activeCount":94},[],{"trials":752,"activeCount":94},[],{"trials":754,"activeCount":94},[],{"trials":756,"activeCount":94},[757],{"nctId":733,"briefTitle":734,"status":350,"phases":758,"primaryCompletion":736,"completion":736,"start":737,"enrollment":302,"conditions":759,"interventions":760},[85],[739],[722,741,742],{"trials":762,"activeCount":94},[],{"trials":764,"activeCount":94},[],{"intervention":742,"totalTrials":90,"cells":766},{"EARLY_PHASE1":767,"PHASE1":769,"PHASE2":771,"PHASE3":773,"PHASE4":779,"NA":781},{"trials":768,"activeCount":94},[],{"trials":770,"activeCount":94},[],{"trials":772,"activeCount":94},[],{"trials":774,"activeCount":94},[775],{"nctId":733,"briefTitle":734,"status":350,"phases":776,"primaryCompletion":736,"completion":736,"start":737,"enrollment":302,"conditions":777,"interventions":778},[85],[739],[722,741,742],{"trials":780,"activeCount":94},[],{"trials":782,"activeCount":94},[],{"intervention":784,"totalTrials":90,"cells":785},"Bezafibrate 200 MG Oral",{"EARLY_PHASE1":786,"PHASE1":788,"PHASE2":790,"PHASE3":792,"PHASE4":806,"NA":808},{"trials":787,"activeCount":94},[],{"trials":789,"activeCount":94},[],{"trials":791,"activeCount":94},[],{"trials":793,"activeCount":94},[794],{"nctId":795,"briefTitle":796,"status":567,"phases":797,"primaryCompletion":798,"completion":799,"start":800,"enrollment":801,"conditions":802,"interventions":804},"NCT04751188","A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis",[85],"2021-06","2021-07","2020-10-02",11,[803],"Primary Biliary Cirrhosis",[784,805],"Ursodeoxycholic Acid",{"trials":807,"activeCount":94},[],{"trials":809,"activeCount":94},[],{"intervention":805,"totalTrials":90,"cells":811},{"EARLY_PHASE1":812,"PHASE1":814,"PHASE2":816,"PHASE3":818,"PHASE4":824,"NA":826},{"trials":813,"activeCount":94},[],{"trials":815,"activeCount":94},[],{"trials":817,"activeCount":94},[],{"trials":819,"activeCount":94},[820],{"nctId":795,"briefTitle":796,"status":567,"phases":821,"primaryCompletion":798,"completion":799,"start":800,"enrollment":801,"conditions":822,"interventions":823},[85],[803],[784,805],{"trials":825,"activeCount":94},[],{"trials":827,"activeCount":94},[],{"intervention":829,"totalTrials":90,"cells":830},"Dexamethasone",{"EARLY_PHASE1":831,"PHASE1":833,"PHASE2":835,"PHASE3":837,"PHASE4":850,"NA":852},{"trials":832,"activeCount":94},[],{"trials":834,"activeCount":94},[],{"trials":836,"activeCount":94},[],{"trials":838,"activeCount":94},[839],{"nctId":840,"briefTitle":841,"status":350,"phases":842,"primaryCompletion":843,"completion":844,"start":845,"enrollment":846,"conditions":847,"interventions":849},"NCT01030614","Dexamethasone Improves Postoperative Symptoms After Laparoscopic Cholecystectomy",[85],"2008-08","2008-12","2007-01",210,[306,14,848],"Postoperative Fatigue",[829],{"trials":851,"activeCount":94},[],{"trials":853,"activeCount":94},[],{"intervention":855,"totalTrials":90,"cells":856},"Indomethacin",{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":861,"PHASE3":863,"PHASE4":877,"NA":879},{"trials":858,"activeCount":94},[],{"trials":860,"activeCount":94},[],{"trials":862,"activeCount":94},[],{"trials":864,"activeCount":94},[865],{"nctId":866,"briefTitle":867,"status":350,"phases":868,"primaryCompletion":869,"completion":870,"start":871,"enrollment":872,"conditions":873,"interventions":875},"NCT02110810","Indomethacin Decreases Post-ERCP Pancreatitis",[85],"2015-01","2015-03","2014-01",160,[874],"Post ERCP Acute Pancreatitis",[855,876],"2.6-g suppository of glycerin",{"trials":878,"activeCount":94},[],{"trials":880,"activeCount":94},[],{"intervention":876,"totalTrials":90,"cells":882},{"EARLY_PHASE1":883,"PHASE1":885,"PHASE2":887,"PHASE3":889,"PHASE4":895,"NA":897},{"trials":884,"activeCount":94},[],{"trials":886,"activeCount":94},[],{"trials":888,"activeCount":94},[],{"trials":890,"activeCount":94},[891],{"nctId":866,"briefTitle":867,"status":350,"phases":892,"primaryCompletion":869,"completion":870,"start":871,"enrollment":872,"conditions":893,"interventions":894},[85],[874],[855,876],{"trials":896,"activeCount":94},[],{"trials":898,"activeCount":94},[],{"intervention":673,"totalTrials":90,"cells":900},{"EARLY_PHASE1":901,"PHASE1":903,"PHASE2":905,"PHASE3":907,"PHASE4":913,"NA":915},{"trials":902,"activeCount":94},[],{"trials":904,"activeCount":94},[],{"trials":906,"activeCount":94},[],{"trials":908,"activeCount":94},[909],{"nctId":661,"briefTitle":662,"status":350,"phases":910,"primaryCompletion":664,"completion":665,"start":666,"enrollment":667,"conditions":911,"interventions":912},[85],[14,669,670],[672,673],{"trials":914,"activeCount":94},[],{"trials":916,"activeCount":94},[],{"intervention":918,"totalTrials":90,"cells":919},"Application of autologous mesenchymal stem cells",{"EARLY_PHASE1":920,"PHASE1":922,"PHASE2":924,"PHASE3":926,"PHASE4":938,"NA":940},{"trials":921,"activeCount":94},[],{"trials":923,"activeCount":94},[],{"trials":925,"activeCount":94},[],{"trials":927,"activeCount":94},[928],{"nctId":929,"briefTitle":930,"status":350,"phases":931,"primaryCompletion":932,"completion":933,"start":934,"enrollment":443,"conditions":935,"interventions":937},"NCT02755922","Bone Regeneration With Mesenchymal Stem Cells",[85],"2010-09","2010-12","2010-04",[936],"Mandibular Fractures",[918],{"trials":939,"activeCount":94},[],{"trials":941,"activeCount":94},[],{"intervention":943,"totalTrials":90,"cells":944},"Rivaroxaban 20 MG [Xarelto]",{"EARLY_PHASE1":945,"PHASE1":947,"PHASE2":949,"PHASE3":951,"PHASE4":969,"NA":971},{"trials":946,"activeCount":94},[],{"trials":948,"activeCount":94},[],{"trials":950,"activeCount":94},[],{"trials":952,"activeCount":94},[953],{"nctId":954,"briefTitle":955,"status":350,"phases":956,"primaryCompletion":957,"completion":958,"start":959,"enrollment":960,"conditions":961,"interventions":966},"NCT05515120","Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events",[84,85],"2022-01-09","2022-07-01","2021-01-03",58,[962,963,964,965],"Venous Thromboembolism","Anticoagulant-induced Bleeding","Venous Thromboses","Pulmonary Embolism",[943,967,968],"Aspirin 300mg","Acenocoumarol Oral",{"trials":970,"activeCount":94},[],{"trials":972,"activeCount":94},[],{"intervention":967,"totalTrials":90,"cells":974},{"EARLY_PHASE1":975,"PHASE1":977,"PHASE2":979,"PHASE3":981,"PHASE4":987,"NA":989},{"trials":976,"activeCount":94},[],{"trials":978,"activeCount":94},[],{"trials":980,"activeCount":94},[],{"trials":982,"activeCount":94},[983],{"nctId":954,"briefTitle":955,"status":350,"phases":984,"primaryCompletion":957,"completion":958,"start":959,"enrollment":960,"conditions":985,"interventions":986},[84,85],[962,963,964,965],[943,967,968],{"trials":988,"activeCount":94},[],{"trials":990,"activeCount":94},[],{"intervention":968,"totalTrials":90,"cells":992},{"EARLY_PHASE1":993,"PHASE1":995,"PHASE2":997,"PHASE3":999,"PHASE4":1005,"NA":1007},{"trials":994,"activeCount":94},[],{"trials":996,"activeCount":94},[],{"trials":998,"activeCount":94},[],{"trials":1000,"activeCount":94},[1001],{"nctId":954,"briefTitle":955,"status":350,"phases":1002,"primaryCompletion":957,"completion":958,"start":959,"enrollment":960,"conditions":1003,"interventions":1004},[84,85],[962,963,964,965],[943,967,968],{"trials":1006,"activeCount":94},[],{"trials":1008,"activeCount":94},[],{"intervention":1010,"totalTrials":90,"cells":1011},"Ropivacaine",{"EARLY_PHASE1":1012,"PHASE1":1014,"PHASE2":1016,"PHASE3":1018,"PHASE4":1034,"NA":1036},{"trials":1013,"activeCount":94},[],{"trials":1015,"activeCount":94},[],{"trials":1017,"activeCount":94},[],{"trials":1019,"activeCount":94},[1020],{"nctId":1021,"briefTitle":1022,"status":350,"phases":1023,"primaryCompletion":1024,"completion":1025,"start":1026,"enrollment":1027,"conditions":1028,"interventions":1032},"NCT02949674","Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients",[85],"2016-10","2017-04","2016-09",93,[1029,1030,1031],"Ankle Fractures","Pain, Postoperative","Local Infiltration",[1010,1033],"Bupivacaine",{"trials":1035,"activeCount":94},[],{"trials":1037,"activeCount":94},[],{"intervention":1033,"totalTrials":90,"cells":1039},{"EARLY_PHASE1":1040,"PHASE1":1042,"PHASE2":1044,"PHASE3":1046,"PHASE4":1052,"NA":1054},{"trials":1041,"activeCount":94},[],{"trials":1043,"activeCount":94},[],{"trials":1045,"activeCount":94},[],{"trials":1047,"activeCount":94},[1048],{"nctId":1021,"briefTitle":1022,"status":350,"phases":1049,"primaryCompletion":1024,"completion":1025,"start":1026,"enrollment":1027,"conditions":1050,"interventions":1051},[85],[1029,1030,1031],[1010,1033],{"trials":1053,"activeCount":94},[],{"trials":1055,"activeCount":94},[],{"intervention":1057,"totalTrials":90,"cells":1058},"Tranexamic acid",{"EARLY_PHASE1":1059,"PHASE1":1061,"PHASE2":1063,"PHASE3":1065,"PHASE4":1076,"NA":1078},{"trials":1060,"activeCount":94},[],{"trials":1062,"activeCount":94},[],{"trials":1064,"activeCount":94},[],{"trials":1066,"activeCount":94},[1067],{"nctId":1068,"briefTitle":1069,"status":567,"phases":1070,"primaryCompletion":1071,"completion":1072,"start":1071,"enrollment":443,"conditions":1073,"interventions":1075},"NCT05855590","Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements",[85],"2022-01-01","2023-12-30",[1074],"Burns",[1057],{"trials":1077,"activeCount":94},[],{"trials":1079,"activeCount":94},[],{"intervention":1081,"totalTrials":90,"cells":1082},"Melatonin",{"EARLY_PHASE1":1083,"PHASE1":1085,"PHASE2":1087,"PHASE3":1089,"PHASE4":1103,"NA":1105},{"trials":1084,"activeCount":94},[],{"trials":1086,"activeCount":94},[],{"trials":1088,"activeCount":94},[],{"trials":1090,"activeCount":94},[1091],{"nctId":1092,"briefTitle":1093,"status":1094,"phases":1095,"primaryCompletion":1096,"completion":1097,"start":1098,"enrollment":94,"conditions":1099,"interventions":1101},"NCT04287543","Melatonin on Clock Genes in Parkinson's Disease","WITHDRAWN",[84,85],"2022-07","2022-08","2021-05",[1100],"Parkinson Disease",[1081,1102],"Placebos",{"trials":1104,"activeCount":94},[],{"trials":1106,"activeCount":94},[],{"intervention":1102,"totalTrials":90,"cells":1108},{"EARLY_PHASE1":1109,"PHASE1":1111,"PHASE2":1113,"PHASE3":1115,"PHASE4":1121,"NA":1123},{"trials":1110,"activeCount":94},[],{"trials":1112,"activeCount":94},[],{"trials":1114,"activeCount":94},[],{"trials":1116,"activeCount":94},[1117],{"nctId":1092,"briefTitle":1093,"status":1094,"phases":1118,"primaryCompletion":1096,"completion":1097,"start":1098,"enrollment":94,"conditions":1119,"interventions":1120},[84,85],[1100],[1081,1102],{"trials":1122,"activeCount":94},[],{"trials":1124,"activeCount":94},[],{"intervention":1126,"totalTrials":90,"cells":1127},"Polyethylene glycol",{"EARLY_PHASE1":1128,"PHASE1":1130,"PHASE2":1132,"PHASE3":1134,"PHASE4":1147,"NA":1149},{"trials":1129,"activeCount":94},[],{"trials":1131,"activeCount":94},[],{"trials":1133,"activeCount":94},[],{"trials":1135,"activeCount":94},[1136],{"nctId":1137,"briefTitle":1138,"status":350,"phases":1139,"primaryCompletion":1140,"completion":1141,"start":1142,"enrollment":1143,"conditions":1144,"interventions":1146},"NCT02731963","Mechanical Bowel Preparation for Elective Colorectal Anastomosis",[85],"2015-02","2016-02","2014-09",81,[1145],"Anastomosis",[1126],{"trials":1148,"activeCount":94},[],{"trials":1150,"activeCount":94},[],{"intervention":1152,"totalTrials":90,"cells":1153},"physiological solution",{"EARLY_PHASE1":1154,"PHASE1":1156,"PHASE2":1158,"PHASE3":1171,"PHASE4":1173,"NA":1175},{"trials":1155,"activeCount":94},[],{"trials":1157,"activeCount":94},[],{"trials":1159,"activeCount":94},[1160],{"nctId":1161,"briefTitle":1162,"status":350,"phases":1163,"primaryCompletion":871,"completion":1164,"start":1165,"enrollment":1166,"conditions":1167,"interventions":1169},"NCT02049411","Ketamine and Changes of the Short Portable Mental Status Questionnaire",[84],"2014-05","2013-06",80,[1168],"Postoperative Cognitive Dysfunction",[1170,1152],"Ketamine",{"trials":1172,"activeCount":94},[],{"trials":1174,"activeCount":94},[],{"trials":1176,"activeCount":94},[],{"intervention":1178,"totalTrials":90,"cells":1179},"Platelet-Rich Plasma",{"EARLY_PHASE1":1180,"PHASE1":1182,"PHASE2":1184,"PHASE3":1196,"PHASE4":1198,"NA":1200},{"trials":1181,"activeCount":94},[],{"trials":1183,"activeCount":94},[],{"trials":1185,"activeCount":94},[1186],{"nctId":1187,"briefTitle":1188,"status":350,"phases":1189,"primaryCompletion":1190,"completion":1191,"start":1192,"enrollment":443,"conditions":1193,"interventions":1195},"NCT03674203","Efficacy of Platelet-rich Plasma in Treatment of Melasma",[84],"2018-05-31","2018-07-31","2017-05-01",[1194],"Melasma",[1178],{"trials":1197,"activeCount":94},[],{"trials":1199,"activeCount":94},[],{"trials":1201,"activeCount":94},[],{"intervention":1203,"totalTrials":90,"cells":1204},"Capsaicin",{"EARLY_PHASE1":1205,"PHASE1":1207,"PHASE2":1209,"PHASE3":1221,"PHASE4":1223,"NA":1225},{"trials":1206,"activeCount":94},[],{"trials":1208,"activeCount":94},[],{"trials":1210,"activeCount":94},[1211],{"nctId":1212,"briefTitle":1213,"status":350,"phases":1214,"primaryCompletion":1215,"completion":1216,"start":1217,"enrollment":443,"conditions":1218,"interventions":1220},"NCT05543837","Capsaicin for Cerebral Perfusion Augmentation",[84],"2022-09-30","2023-02-28","2022-09-20",[1219],"Cerebral Circulatory Disorder",[1203],{"trials":1222,"activeCount":94},[],{"trials":1224,"activeCount":94},[],{"trials":1226,"activeCount":94},[],{"intervention":1228,"totalTrials":90,"cells":1229},"Subcutaneous polyvidone collagen",{"EARLY_PHASE1":1230,"PHASE1":1232,"PHASE2":1234,"PHASE3":1246,"PHASE4":1248,"NA":1250},{"trials":1231,"activeCount":94},[],{"trials":1233,"activeCount":94},[],{"trials":1235,"activeCount":94},[1236],{"nctId":1237,"briefTitle":1238,"status":350,"phases":1239,"primaryCompletion":1240,"completion":1241,"start":1242,"enrollment":520,"conditions":1243,"interventions":1245},"NCT06656169","Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.",[83,84],"2023-01-06","2023-01-07","2021-01-01",[1244],"Arthritis, Rheumatoid",[1228],{"trials":1247,"activeCount":94},[],{"trials":1249,"activeCount":94},[],{"trials":1251,"activeCount":94},[],{"intervention":1253,"totalTrials":90,"cells":1254},"30% icodextrin and 10% dextrose",{"EARLY_PHASE1":1255,"PHASE1":1257,"PHASE2":1269,"PHASE3":1271,"PHASE4":1273,"NA":1275},{"trials":1256,"activeCount":94},[],{"trials":1258,"activeCount":94},[1259],{"nctId":1260,"briefTitle":1261,"status":567,"phases":1262,"primaryCompletion":1263,"completion":1072,"start":1264,"enrollment":1265,"conditions":1266,"interventions":1268},"NCT05780086","Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution",[83],"2023-08-30","2023-02-03",10,[1267],"Chronic Kidney Diseases",[1253],{"trials":1270,"activeCount":94},[],{"trials":1272,"activeCount":94},[],{"trials":1274,"activeCount":94},[],{"trials":1276,"activeCount":94},[],{"intervention":1170,"totalTrials":22,"cells":1278},{"EARLY_PHASE1":1279,"PHASE1":1281,"PHASE2":1283,"PHASE3":1289,"PHASE4":1291,"NA":1293},{"trials":1280,"activeCount":94},[],{"trials":1282,"activeCount":94},[],{"trials":1284,"activeCount":94},[1285],{"nctId":1161,"briefTitle":1162,"status":350,"phases":1286,"primaryCompletion":871,"completion":1164,"start":1165,"enrollment":1166,"conditions":1287,"interventions":1288},[84],[1168],[1170,1152],{"trials":1290,"activeCount":94},[],{"trials":1292,"activeCount":94},[],{"trials":1294,"activeCount":94},[1295],{"nctId":1296,"briefTitle":1297,"status":350,"phases":1298,"primaryCompletion":1299,"completion":1300,"start":1301,"enrollment":1302,"conditions":1303,"interventions":1305},"NCT03473431","Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment.",[87],"2018-06-30","2018-07-30","2018-04-15",90,[1304,1170],"Depression in Old Age",[1170],{"intervention":1307,"totalTrials":90,"cells":1308},"Pharmacotherapy without diet",{"EARLY_PHASE1":1309,"PHASE1":1311,"PHASE2":1313,"PHASE3":1315,"PHASE4":1317,"NA":1319},{"trials":1310,"activeCount":94},[],{"trials":1312,"activeCount":94},[],{"trials":1314,"activeCount":94},[],{"trials":1316,"activeCount":94},[],{"trials":1318,"activeCount":94},[],{"trials":1320,"activeCount":94},[1321],{"nctId":1322,"briefTitle":1323,"status":350,"phases":1324,"primaryCompletion":1325,"completion":1326,"start":1327,"enrollment":1328,"conditions":1329,"interventions":1331},"NCT03183076","Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy",[87],"2016-04-30","2016-12-30","2015-09-01",14,[1330],"Epilepsy, Drug Resistant",[1307],{"intervention":1333,"totalTrials":90,"cells":1334},"Intaarticular lidocain",{"EARLY_PHASE1":1335,"PHASE1":1337,"PHASE2":1339,"PHASE3":1341,"PHASE4":1343,"NA":1345},{"trials":1336,"activeCount":94},[],{"trials":1338,"activeCount":94},[],{"trials":1340,"activeCount":94},[],{"trials":1342,"activeCount":94},[],{"trials":1344,"activeCount":94},[],{"trials":1346,"activeCount":94},[1347],{"nctId":1348,"briefTitle":1349,"status":350,"phases":1350,"primaryCompletion":1351,"completion":1352,"start":1353,"enrollment":545,"conditions":1354,"interventions":1359},"NCT03795805","After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet",[87],"2018-11-20","2018-12-20","2018-03-15",[1355,1356,1357,1358],"Arthroplasty, Replacement, Knee","Acute Kidney Injury","Tourniquets","Knee Osteoarthritis",[1333],{"intervention":1361,"totalTrials":90,"cells":1362},"zoledronic acid",{"EARLY_PHASE1":1363,"PHASE1":1365,"PHASE2":1367,"PHASE3":1369,"PHASE4":1371,"NA":1373},{"trials":1364,"activeCount":94},[],{"trials":1366,"activeCount":94},[],{"trials":1368,"activeCount":94},[],{"trials":1370,"activeCount":94},[],{"trials":1372,"activeCount":94},[],{"trials":1374,"activeCount":94},[1375],{"nctId":1376,"briefTitle":1377,"status":350,"phases":1378,"primaryCompletion":1379,"completion":1379,"start":1380,"enrollment":1381,"conditions":1382,"interventions":1384},"NCT01234129","Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma",[],"2009-12","2002-06",320,[1383],"Multiple Myeloma",[1361],{"intervention":1386,"totalTrials":90,"cells":1387},"Tumescent Anesthesia",{"EARLY_PHASE1":1388,"PHASE1":1390,"PHASE2":1392,"PHASE3":1394,"PHASE4":1396,"NA":1398},{"trials":1389,"activeCount":94},[],{"trials":1391,"activeCount":94},[],{"trials":1393,"activeCount":94},[],{"trials":1395,"activeCount":94},[],{"trials":1397,"activeCount":94},[],{"trials":1399,"activeCount":94},[1400],{"nctId":1401,"briefTitle":1402,"status":350,"phases":1403,"primaryCompletion":1404,"completion":1405,"start":1406,"enrollment":597,"conditions":1407,"interventions":1409},"NCT03914235","Anesthesia Tumescent for Surgical Management of Tenosynovitis.",[87],"2019-03-31","2019-04-08","2018-08-01",[1408],"Tenosynovitis",[1386,1410],"Lidocaine",{"intervention":1410,"totalTrials":90,"cells":1412},{"EARLY_PHASE1":1413,"PHASE1":1415,"PHASE2":1417,"PHASE3":1419,"PHASE4":1421,"NA":1423},{"trials":1414,"activeCount":94},[],{"trials":1416,"activeCount":94},[],{"trials":1418,"activeCount":94},[],{"trials":1420,"activeCount":94},[],{"trials":1422,"activeCount":94},[],{"trials":1424,"activeCount":94},[1425],{"nctId":1401,"briefTitle":1402,"status":350,"phases":1426,"primaryCompletion":1404,"completion":1405,"start":1406,"enrollment":597,"conditions":1427,"interventions":1428},[87],[1408],[1386,1410],{"intervention":1430,"totalTrials":90,"cells":1431},"banding ligation plus terlipressin",{"EARLY_PHASE1":1432,"PHASE1":1434,"PHASE2":1436,"PHASE3":1438,"PHASE4":1440,"NA":1442},{"trials":1433,"activeCount":94},[],{"trials":1435,"activeCount":94},[],{"trials":1437,"activeCount":94},[],{"trials":1439,"activeCount":94},[],{"trials":1441,"activeCount":94},[],{"trials":1443,"activeCount":94},[1444],{"nctId":1445,"briefTitle":1446,"status":350,"phases":1447,"primaryCompletion":1448,"completion":1448,"start":1242,"enrollment":1449,"conditions":1450,"interventions":1452},"NCT05331768","Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy",[87],"2021-09-30",109,[1451],"Esophageal and Gastric Varices",[1430],{"intervention":1454,"totalTrials":90,"cells":1455},"phytomenadione",{"EARLY_PHASE1":1456,"PHASE1":1458,"PHASE2":1460,"PHASE3":1462,"PHASE4":1464,"NA":1466},{"trials":1457,"activeCount":94},[],{"trials":1459,"activeCount":94},[],{"trials":1461,"activeCount":94},[],{"trials":1463,"activeCount":94},[],{"trials":1465,"activeCount":94},[],{"trials":1467,"activeCount":94},[1468],{"nctId":1469,"briefTitle":1470,"status":350,"phases":1471,"primaryCompletion":1472,"completion":1473,"start":1474,"enrollment":597,"conditions":1475,"interventions":1477},"NCT04247087","Effects of Fhytomenadione on Coronary Artery Calcification of Hemodialysis Patients",[87],"2019-09-27","2020-01-02","2017-09-07",[1476],"Coronary Calcification",[1454],{"intervention":1479,"totalTrials":90,"cells":1480},"Dapagliflozin 10Mg Tab",{"EARLY_PHASE1":1481,"PHASE1":1483,"PHASE2":1485,"PHASE3":1487,"PHASE4":1489,"NA":1491},{"trials":1482,"activeCount":94},[],{"trials":1484,"activeCount":94},[],{"trials":1486,"activeCount":94},[],{"trials":1488,"activeCount":94},[],{"trials":1490,"activeCount":94},[],{"trials":1492,"activeCount":94},[1493],{"nctId":1494,"briefTitle":1495,"status":350,"phases":1496,"primaryCompletion":1497,"completion":1498,"start":1499,"enrollment":1500,"conditions":1501,"interventions":1505},"NCT04717986","Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)",[87],"2022-06-30","2023-06-20","2021-01-26",188,[547,1502,1503,1504],"Cardiovascular Morbidity","Heart Failure","Angina, Unstable",[1479],{"intervention":1507,"totalTrials":90,"cells":1508},"Magnesium Sulfate 10 MG\u002FML",{"EARLY_PHASE1":1509,"PHASE1":1511,"PHASE2":1513,"PHASE3":1515,"PHASE4":1517,"NA":1519},{"trials":1510,"activeCount":94},[],{"trials":1512,"activeCount":94},[],{"trials":1514,"activeCount":94},[],{"trials":1516,"activeCount":94},[],{"trials":1518,"activeCount":94},[],{"trials":1520,"activeCount":94},[1521],{"nctId":1522,"briefTitle":1523,"status":567,"phases":1524,"primaryCompletion":569,"completion":1525,"start":1526,"enrollment":151,"conditions":1527,"interventions":1528},"NCT05843812","Magnesium Sulfate in Bariatric Surgery",[],"2024-06-30","2023-04-21",[573,574,19],[1507]]